Evolution of the Average Target: Arkema

Evolution of the Target Price: Arkema

Changes in Analyst Recommendations: Arkema

12c95bd388538050a1e9.04yOwEXp7LUZzhVj892_rc5_eqswqRF4lHNnF8bKGbQ.gMPjsjDch_129kAllpvsm78WH8df-nMs_TEDYouwLOCJtcWrCaCL71i3QA~c250766edcfe77153aa3e3536fa8d422
12/08 Barclays Upgrades Arkema to Equalweight, Raises PT MT
31/07 Arkema: A strong Q2 but limited visibility for H2 Alphavalue
09/07 AlphaValue/Baader Europe Downgrades Arkema to Add, Cuts PT MT
09/07 Arkema: More cautious on demand and pricing Alphavalue
30/06 AlphaValue/Baader Europe Upgrades Arkema to Buy, Lifts PT MT
26/06 On Field Investment Research Downgrades Arkema to Neutral, Cuts PT MT
23/06 Deutsche Bank Raises Its Price Target on Arkema Zonebourse
08/06 Goldman Sachs Downgrades Arkema to Neutral, Lowers PT MT
08/06 Arkema retreats following Goldman Sachs downgrade Zonebourse
22/05 Analyst Ratings France: JP Morgan turns bearish on Arkema, HSBC raises Nexans target Zonebourse
07/05 Kepler Cheuvreux Downgrades Arkema to Reduce MT
07/05 Arkema: Key upstream solutions defend broader softness Alphavalue
04/05 Arkema holds firm despite AlphaValue downgrade Zonebourse
04/05 Arkema: A more conservative stance Alphavalue
20/04 Bernstein Upgrades Arkema to Market Perform, Boosts PT MT
20/04 Berenberg downgrades Arkema to Hold following recent share price rally Zonebourse
20/04 Arkema Downgraded to Hold as Berenberg Warns 'Good Times May Not Stick' MT
09/04 Arkema unmoved by Deutsche Bank note Zonebourse
27/03 Evonik hits annual high following Morgan Stanley upgrade DP
18/03 Sulfur and methanol prices soar on Middle East conflict Alphavalue
05/03 Berenberg Cuts Arkema EPS Projections After 'Tough' Q4 2025; Price Target Up MT
04/03 Middle East tensions intensify pessimism in chemicals Alphavalue
27/02 Kepler Cheuvreux Downgrades Arkema to Hold, Raises PT MT
27/02 Arkema: Earnings decline on soft demand and destocking Alphavalue
26/02 Arkema: Macroeconomic headwinds weigh on Arkema Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+4.11%
+15.73%
+7.31%
+10.73%
+27.67%
-6.55%
+13.85%
+22.47%
+30.78%
+6.55%
Average +13.27%
Weighted average by Cap. +13.61%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
60.45EUR
Average target price
62.47EUR
Spread / Average Target
+3.34%
High Price Target
80.00EUR
Spread / Highest target
+32.34%
Low Price Target
50.00EUR
Spread / Lowest Target
-17.29%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barclays
alphavalue Akash Nandy
AlphaValue/Baader Europe
On Field Investment Research
Goldman Sachs
Kepler Cheuvreux
Bernstein
Deutsche Bank Research
CIC Market Solutions
Rothschild & Co Redburn
Jefferies & Co.
Citigroup
BNP Paribas
Redburn
Berenberg Bank
UBS
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
60.45EUR
Average target price
62.47EUR
Spread / Average Target
+3.34%

Quarterly revenue - Rate of surprise